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Abstract
Magnetic nano drug targeting, through the use of an external magnetic field,
is a new technique for the treatment of several diseases, which can potentially
avoid the dispersion of drugs in undesired locations of the body. Nevertheless,
due to the limitations on the intensity of the magnetic field applied, the hydro-
dynamic forces can reduce the effectiveness of the procedure. This technique is
studied in this paper with the Computational Fluid Dynamics (CFD), focusing
on the influence of the magnetic probe position, and the direction of the circu-
lating electric current. A single rectangular coil is used to generate the external
magnetic field. A patient-specific geometry of the coeliac trunk is reconstructed
from DICOM images, with the use of VMTK. A new solver, coupling the La-
grangian dynamics of the nanoparticles with the Eulerian dynamics of the blood,
is implemented in OpenFOAM to perform the simulations. The resistive pres-
sure, the Womersley’s profile for the inlet velocity and the magnetic field of a
rectangular coil are implemented in the software as boundary conditions. The
results show the influence of the position of the probe, as well as the limitations
associated with the rectangular coil configuration.
Keywords: Magnetic Hydro Dynamics, Patient-Specific, Nanoparticles,
Lagrangian model, Eulerian model, Coeliac Trunk.
1. Introduction
The liver tumor results from a quick proliferation of the cells. The primary
hepatic tumors, called hepatocellular tumors, are born inside the hepatic cells
and spread towards bones and lungs. It is a rare condition but its mortality is
quite high, as the World Health Organization has reported a number of death
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equals to 745.000 during 2012, which is the second cause of death among com-
mon cancers. Moreover, it is mostly widespread in Asia, accounting for 782.000
new cancer cases only in 2012. A smaller number of cases per year is reported
in USA and Europe, e.g. in Southern Europe the incidence is 9.5% and in
Northern Europe only 4.6%, which can be compared to 2% of overall tumors
[1]. Nowadays, it is impossible to prevent this disease except avoiding the main
risk factors, such as alcohol excess and hepatitis viruses. Chemotherapy can
ensure a good quality of life, avoiding the spread of the metastasis. However,
these drug treatments can have numerous hazardous side effects.
In the last few years, new technologies have been developed in order to
decrease these undesired side effects. In the magnetic drug delivery the drugs
are guided directly to the interested regions of the body and the absorption in
other organs, or systems, not interested by the tumor, decreases, which results
in a higher quality of life of the patient.
The study of Magneto Hydro Dynamics (MHD) started in the late 30s by
Hartmann and Lazarus [2], who investigated the flow of an incompressible New-
tonian fluid inside a duct, under the influence of an external magnetic field.
The first analytical characterization of the problem has been done by Shercliff
at the end of the 50s [3], who, later on, investigated the flow at high Hartmann
numbers [4]. At the beginning of the 60s, Gold [5] obtained the solution for the
steady one-dimensional flow of an incompressible, viscous, electrically conduct-
ing fluid, through a circular pipe, in presence of an applied uniform magnetic
field. The early studies were performed for liquid metals, and only in the 90s
the research was extended to biological fluids [6, 7]. Several applications in bio-
engineering and medicine have been developed since then. Among them, the
targeted transport of drugs by external magnetic fields and magnetic tracers are
of particular interest [3, 8].
The blood is the most important biological fluid, composed by plasma and
erythrocytes, which contain hemoglobin, whose main molecule is iron. The pres-
ence of this element allows the blood to be magnetized in presence of an electro-
magnetic field. In the deoxygenated state, the blood behaves as a paramagnetic
material with a magnetic susceptibility of χ = 3.5 · 10−6, while, in the oxy-
genated state, the blood is diamagnetic and its susceptibility is χ = −6.6 · 10−7
[9].
Several studies have been conducted to investigate the blood velocity profile
inside the human circulatory system, both for healthy and non-healthy patients.
In the last decades, some experimental data have been compared with numerical
results, obtained with the Computational Fluid Dynamics (CFD), a technique
well established in biomedical applications [10–16]. The influence of geometrical
factors on pathological conditions has been investigated, suggesting that the
most important factor to be taken into account is the velocity field, whose
measurements can be provided by Doppler Ultra Sound and MRI [17, 18]. Long
et al. [19] reconstructed the blood flow in the carotid bifurcation from MRI
images. Moreover, Moulinier et al. [18] used the Doppler echocardiography to
get information on the blood flow in the aortic arch.
Some studies investigated the effect of the magnetic field on metal nanopar-
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ticles embedded in the blood flow, and their use as drug carriers [20–22]. Other
investigations on drug delivery have been performed on non-biological fluid [17]
and on clinical trials of cancer patients [23, 24]. A few CFD studies have been
conducted to simulate the magnetic drug targeting. In [25], the behavior of
magnetic particles in blood vessels and surrounding tissue has been analyzed
in a cylindrical geometry by solving the particle concentration and including
a “magnetic drift” term. In [26], a numerical simulations of blood flow and
magnetic drug carrier distributions in a patient-specific brain vascular system
has been reported. The blood was represented as a non-Newtonian power-law
fluid, neglecting the influence of the Lorentz force. A Lagrangian approach
was used to simulate the particle tracking, neglecting the buoyancy and the
carrier phase inertia. The Lorentz force has been introduced in [27], with a
Lagrangian particle tracking algorithm to simulate magnetic drug delivery in
a two-dimensional bifurcation. In [28], the nanoparticle sticking-steering rela-
tionship has been investigated using Lagrangian particle tracking. In [29, 30],
magnetic drug delivery has been studied in a three-dimensional bifurcation using
Lagrangian particle tracking.
The present study investigates the fluid dynamics of blood in the coeliac
trunk, where nanoparticles, used for drug targeting, are dragged into the liver
by an external magnetic field. A patient-specific geometry is reconstructed from
a data set of CT scan images of a middle-aged healthy man. The blood is treated
as a continuum medium and therefore an Eulerian formulation is employed to
describe it, while the nanoparticles are treated with a Lagrangian approach.
A rectangular coil is employed as source of the external magnetic field. The
influence of the probe position and the current intensity are investigated.
2. Materials and Methods
2.1. Domain reconstruction
The geometrical model is made with the open-source software VMTK (The
Vascular Modelling Toolkit) [31], which reconstructs a real artery from a DI-
COM series of images. Since the procedure is operator-dependent, the non-
interesting structures and artefacts are removed manually. The Level Set Seg-
mentation algorithm is applied to reconstruct the surface of the artery [6], which
is refined with the parametric deformable models, initialized with the Colliding
Front methodology. The output of the Level Set Segmentation algorithm is an
image, and the Marching Cubes algorithm is used to reconstruct the surface,
due to the depth of the interested vessel.
Flow extensions of cylindrical shapes are added at the inlets and outlets of
the domain, to ensure that the flow, entering and leaving the computational
domain, is fully developed. In this work, the length of each flow extension has
been set equal to 3 times its diameter. This approach allows using standard
boundary conditions (BC) to solve the partial differential equations (PDE) gov-
erning the phenomenon. Once the flow extensions are added, the computational
grid, which solves the discretized equations, is generated [6].
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Figure 1: (a) Application of the Marching Cubes algorithm to obtain a reconstruction of the
Abdominal Aorta with its collateral structures; (b) Detail of the geometry used in this study.
An adaptive mesh is generated in order to have a more refined grid close to
the wall. Refinement is requested for the coeliac trunk, since the dimensions of
its branches are smaller than the Thoracic Aorta (TA). Tetrahedral elements
are used for the computational grid. The minimum and maximum dihedral
angles are set up in order to reduce the skew angle and the number of non-
orthogonal cells. Three grids are created with different number of elements,
respectively 183, 498 (grid1), 324, 577 (grid2) and 626, 875 (grid3), to verify
that the numerical solutions are grid-independent.
The domain is shown in Fig.(1), where Fig.(1,a) presents the reconstruction
obtained with the application of the Marching Cubes algorithm, while Fig.(1,b)
shows the segments used for the numerical simulations. The three main branches
of the coeliac trunk, i.e. Left Gastric Artery (LGA), Common Hepatic Artery
(CHA), and Splenic Artery (SA) are represented.
2.2. Eulerian Model
The MHD mathematical model is based on the coupling between the Navier-
Stokes equations and the Maxwell ones. It is known that an external magnetic
field can change the direction of a moving charged particle, and the force re-
sponsible for it is known as the Lorentz force [32]. The MHD equations can be
written for incompressible flow of a viscous, conducting liquid
div (~vb) = 0 (1)
4
∂~vb
∂t
+ (~vb · ∇)~vb = − 1
ρb
∇p+ νb∇2~vb + ~g + 1
ρbµ0
curl
(
~B
)
× ~B (2)
∂ ~B
∂t
+ (~vb · ∇) ~B =
(
~B · ∇
)
~vb +
1
σbµ0
∇2 ~B (3)
where the subscript b denotes blood, νb is the kinematic viscosity, ρb the
density, µ0 the magnetic permeability in the vacuum, which is approximately
the same of the blood, σb the electric conductivity, ~g the gravity acceleration, p
the static pressure, ~vb the velocity field, and ~B the magnetic induction field.
The momentum conservation equation, Eq.(2), does not take into account
the momentum which the particles transfer to the blood and the last term rep-
resents the Lorentz force in the context of continuum mechanics. According to
[33, 34] for particle volume fractions less than 10−6, particle motion is influenced
by continuous phase properties while practically there is no feedback from the
dispersed phase.
The particle diameter used in this work is 5nm, which is typical of gold/iron-
oxide nanoparticles [35, 36]. Therefore, we assumed that the inertia of the
magnetic particles is much smaller than the blood, which is justified by their
small volume of the order of 65nm3.
2.3. Lagrangian Model
A particle of diameter dp, velocity ~vp, and density ρp, is defined by the
position of its center, ~xp. In a Lagrangian frame of reference, the position of
each particle is obtained by the integration of its velocity,
d~xp
dt
= ~vp (4)
which is evaluated from the momentum conservation equation, written as
follows
d~vp
dt
= − 1
τp
(
~vp − ~vb +
d2p
12
∇2~vb
)
︸ ︷︷ ︸
(I)
+
(
1− ρb
ρp
)
~g︸ ︷︷ ︸
(II)
+
ρb
ρp
(
∂~vb
∂t
+ (~vb · ∇)~vb
)
︸ ︷︷ ︸
(III)
+
1
2
ρb
ρp
(
∂~vb
∂t
+ (~vb · ∇)~vb − d~vp
dt
)
︸ ︷︷ ︸
(IV )
+
(
qp
mp
~vp − 1
ρpµ0
curl
(
~B
))
× ~B︸ ︷︷ ︸
(V )
(5)
Where (I) is the drag term, (II) is the buoyancy, (III) is the carrier phase
inertia, (IV ) is the added mass and (V ) is the Lorentz force. It must be noted
that in Eq.(5) we have neglected the particle-particle interactions. This as-
sumption has been made because of the small volume of the particles, which
reduces the probability of collision. Moreover, the intra-particle interactions are
computationally demanding, and dont seem to be important in this study.
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Furthermore, qp is the electric charge of the particle, mp its mass and τp the
relaxation time of the particle, defined as
τp =
4
3
ρpdp
ρbCd |~vb − ~vp| (6)
The standard definition of the drag coefficient, according to the derivation
from Schiller and Neumann [37], is the following
Cd =

24
Rep
Rep < 0.1
24
Rep
(
1 + 16Re
2/3
p
)
0.1 < Rep < 1000
0.44 Rep > 1000
(7)
The particle Reynolds number is
Rep =
dp |~vb − ~vp|
νb
(8)
2.4. Boundary Conditions (BC)
The solution of the Eulerian system requires appropriate boundary condi-
tions (BC) for each field. A non-slip BC has been imposed for the velocity at
the wall. As far as the outlets are concerned, a mixed BC has been used. If the
blood leaves the domain, the velocity normal derivative is set to zero, whereas
if blood enters through the boundary, the tangential velocity is set to zero. The
velocity profile is imposed on the inlet. In the steady state a parabolic profile
is used, whereas in unsteady state a Womersley-Evans profile is employed, in
analogy with [14].
vb (t, ξ) = 8
Q
piD2
(
1− ξ2)+ 2<( N∑
n=1
VnΦ (τn, ξ) e
jωnt
)
(9)
where
Φ (τn, ξ) =
J0 (τn)− J0 (τnξ)
J0 (τn)− 2J1 (τn) /τn (10)
and
τn = j
3
2
D
2
√
ρ
µ∞
ωn = j
3
2αn (11)
Being r the radial coordinate, D the diameter of the ascending Aorta, Q
the volumetric flow rate, ξ = 2r/D, J0 and J1 the zeroth and first-order Bessel
functions of the first kind, αn the Womersley numbers of order n, < () the real
part of a complex number, j =
√−1, Vn the Fourier coefficients of the pulsatile
mean velocity profile and the number of harmonics used to reproduce the flow
rate. The first ten Fourier coefficients of the flow rate in the ascending aorta
are used to reconstruct the velocity profile, according to the experiments [38].
The reconstructed flow rate is shown in Fig.(2)
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Figure 2: Aorta’s Volumetric Flow Rate vs time.
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As far as the pressure is concerned, a constant total value, equal to the sum
of the static and dynamic ones, is imposed on the outlet of the Abdominal Aorta
(AA). On the other outlets the resistive BC, derived in [39], is used
p = pb +RQ (12)
being pb the reference pressure at the right atrium and R the hydraulic re-
sistance. The value of the resistance and the reference pressure are extrapolated
from the steady state simulations by imposing the volumetric flow rates and a
zero normal derivative for the pressure. The values of the flow rates, in steady
state, for the different outlets are derived from the literature [40–42].
2.5. Magnetic Induction BC
As far as the magnetic induction field is concerned, the normal derivative are
set to zero everywhere, except on the wall, where the magnetic field of the probe
is imposed. The external magnetic field is generated by a single rectangular coil,
with a negligible cross section of the wire, where an electric current flows. This
geometry is quite common in clinical practice [43–46]. The analytical expression
for the magnetic induction field is derived as in [47].
The analytical expression for the magnetic induction field is derived. A
point in the coil reference frame, whose origin is at its center, is identified by
the coordinates (x′, y′, z′). The coil dimensions are 2a1 along the x′ axis and 2b1
in the y′ direction. The axis z′ is normal of the coil surface. The components
of the magnetic induction field are
Bx′ =
µ0I1
4pi
4∑
a=1
[
z′(−1)a+1
ra [ra + da]
]
(13)
By′ =
µ0I1
4pi
4∑
a=1
 z′(−1)a+1
ra
[
ra + Ca(−1)a+1
]
 (14)
Bz′ =
µ0I1
4pi
4∑
a=1
 da(−1)a
ra
[
ra + Ca(−1)a+1
] − Ca
ra [ra + da]
 (15)
with 
C1 = −C4 = a1 + x′
C2 = −C3 = a1 − x′
d1 = d2 = y
′ + b1
d3 = d4 = y
′ − b1
ra =
√
C2a + d
2
a + z
′2
(16)
The magnetic probe is located 1cm above the patient skin, in order for its
modulus to be smaller than 1.5T, which is the limit allowed in clinical treatments
[48], since higher values can cause damage to the patient. The liver is the target
8
Normal CoilCoords(m) TargetCoords(m) Bz|1cm(mT)
nx = 0.05899 xc,1 = 0.003678 xt,1 = 0.9983
1strun ny = 0.94519 yc,1 = −0.12346 yt,1 = −0.056 46.21
nz = 0.32114 zc,1 = −0.14145 zt,1 = −0.019
nx = 0.05899 xc,2 = 0.003678 xt,2 = 0.9983
2ndrun ny = 0.94519 yc,2 = −0.12346 yt,2 = −0.056 −46.21
nz = 0.32114 zc,2 = −0.14145 zt,2 = −0.019
nx = 0.05303 xc,3 = 0.001322 xt,3 = 0.9986
3rdrun ny = 0.97961 yc,3 = −0.12699 yt,3 = −0.052 46.21
nz = 0.19377 zc,3 = −0.12485 zt,3 = −0.0103
nx = 0.05303 xc,4 = 0.001322 xt,4 = 0.9986
4thrun ny = 0.97961 yc,4 = −0.12699 yt,4 = −0.052 −46.21
nz = 0.19377 zc,4 = −0.12485 zt,4 = −0.0103
Table 1: Source and target coordinates; values for the normal to the abdomen surface of the
patient; intensity of the Magnetic field along the z-axis.
HD(cm) WD(cm) DD(cm) DM−T (cm) TO(s) Rem
17.1 4.0 8.37 12 2 1097
Table 2: Simulation Parameters: HD (domain height), WD (domain width), DD (domain
depth), DS−T (magnet-tumor distance), TO (observation time), Rem (mean aortic Reynolds
number).
of the magneto-therapy, and the maximum magnetic field must be concentrated
on it. Therefore, the distance between the origin of the probe and the target
must be parallel to the z′ axis.
The external abdominal surface of the patient is reconstructed using VMTK
with the procedure previously illustrated for the arteries, and the two geometries
are located in the same reference frame in order to calculate the coordinates of
the probe and the target. The dimensions of the rectangular coil, the current
intensity and the positions of coil and target can be found in Tab.(1), while the
main simulation parameters are reported in Tab.(2)
2.6. Numerical Details
The simulations have been performed using the OpenFOAM code, which
solves the governing equations though the Finite Volume Method (FVM). De-
spite the software offers a variety of precompiled solvers, the solution of the
present problem required the implementation of a new one, which couples the
Lagrangian particle dynamics with the Eulerian MHD. We developed this solver
and called it mhdParticle4BFoam. We also implemented new BCs in Open-
FOAM through the utility groovyBC: the resistive BC and the Womersley pro-
file at the inlet for the unsteady simulations, as well as the parabolic profile for
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the steady state ones. We also developed a new BC for the magnetic probe in
an external module, called rectMagProbe. The simulations are carried on for 2
cardiac cycles, considering a period of 1s and a variable time step, in order to
guarantee a Courant number always smaller than 0.5.
3. Results and Discussion
3.1. Solver Validation
The solver mhdParticle4BFoam couples the Lagrangian particle dynamics
with the Eulerian MHD. A far as the MHD equations are concerned, there are
few numerical solutions for channel [3], and pipe flow [4, 5]. As far as the La-
grangian particle dynamics is concerned, an analytical solution for the motion
of a single particle moving in a viscous fluid in the presence of an external mag-
netic field can be found only under four restrictive hypothesis: (i) the particle
is initially at the center of a channel whose width is much larger than its height
and where the velocity gradient and the induced magnetic field are zero; (ii) the
magnetic field applied is uniform; (iii) the flow is fully developed; (iv) the parti-
cle Reynolds number is small. Calling up, vp, wp respectively the axial, vertical
and span-wise particle velocities and B0 the external uniform magnetic field,
applied in the vertical direction, Eq.(5) reduces to:
(
1 + 12
ρb
ρp
)
dup
dt ≈ − 1τp (up − Umax)−
qp
mp
B0wp(
1 + 12
ρb
ρp
)
dvp
dt ≈ − 1τp vp −
(
1− ρbρp
)
g(
1 + 12
ρb
ρp
)
dwp
dt ≈ − 1τpwp +
qp
mp
B0up
(17)
and defining: 
τr = τp
(
1 + 12
ρb
ρp
)
ωB =
qpB0
mp
(
1 + 12
ρb
ρp
)−1
up,∞ = Umax
(
1 + (ωBτr)
2
)−1
vp,∞ = −τp
(
1− ρbρp
)
g
wp,∞ = ωBτrUmax
(
1 + (ωBτr)
2
)−1
(18)
we obtain:

up (t) ≈ up,∞ − (up,∞ − up,0) e− tτr cos (ωBt) + (wp,∞ − wp,0) e− tτr sin (ωBt)
vp (t) ≈ vp,0e− tτr + vp,∞
(
1− e− tτr
)
wp (t) ≈ wp,∞ − (wp,∞ − wp,0) e− tτr cos (ωBt)− (up,∞ − up,0) e− tτr sin (ωBt)
(19)
The comparison between the theories can be seen in Fig.(3). The agreement
between the theory and simulation is quite good, especially for the Eulerian
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Figure 3: Solver validation tests. (a) numerical axial velocity vs theoretical axial velocity from
[3]; (b) numerical particle axial velocity vs theoretical velocity from Eq.(19); (c) numerical
particle vertical velocity vs theoretical velocity from Eq.(19); (d) numerical particle span-wise
velocity vs theoretical velocity from Eq.(19).
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part, i.e. Fig.(3,a). As far as the Lagrangian part is concerned, the agreement
is good for the axial and vertical velocities, except for high Hartmann numbers,
i.e. Ha = 100. For the span-wise velocity, as Fig.(3,d) shows, the agreement is
less satisfactory. However, it must be noted that the span-wise velocity is much
smaller than the settling velocity vs, so the absolute numerical error is quite
small. Further details on the validation can be found in [49].
3.2. Steady State Simulations
The steady state simulations are carried out until convergence is reached with
the simpleFoam solver of OpenFOAM, which solves the Navier-Stokes equations
in steady state. The results of the three meshes, i.e. grid1, grid2, grid3, are
compared using the utility mapFields of OpenFOAM, which maps the fields
from one grid to another. The wall shear stress (WSS), defined as
τwall = iˆaxis·ρbνb ([I]− nˆwall ⊗ nˆwall)
(
[∇~vb] + [∇~vb]T − 2
3
div (~vb) [I]
)
wall
nˆwall
(20)
is used to evaluate the grid independence. The contours of WSS are shown in
Figure 4. The maximum WSS increases from grid1 to grid2, which means that
grid1 has not enough resolution to resolve the velocity gradients. As far as grid2
and grid3 are concerned, the WSS values do not change significantly. Therefore,
grid2 is employed to perform the unsteady simulations, being a compromise
between speed of execution and accuracy.
Figure 4 shows that the WSS is low in the Aorta, due to the small velocity
gradient, growing in the coeliac trunk and reaching the maximum in the LGA.
In proximity of a bifurcation, or in presence of a bending, the WSS increases.
Near the bifurcation of the coeliac trunk, the laminar flow impinges on the
endothelial, and consequently the bifurcation is subject to higher WSS. The
same behavior is also visible near the second bifurcation, where the coeliac
trunk is subdivided in three branches: the LGA, CHA and SA. Overall, the
order of magnitude of the WSS seems to be the same in all the branches of
the coeliac trunk. This is due to the fact that the flow rate decreases with the
section, in agreement with the literature [40–42]. Some exception can be seen
in the LGA, where local peaks of WSS can be observed due to the presence of
high curvature segments.
3.3. Unsteady State Simulations without external magnetic field
The unsteady simulations without external magnetic field are carried out by
fixing the value of the current intensity to zero. As far as the inlet velocity is
concerned, the pulsatile blood profile, derived from the Womersley equation, is
imposed.
Figure 5 shows the time variations of the pressure field on the artery wall,
which is representative of the pressure inside the whole domain at six different
time steps of the cardiac cycle. The pressure variations during the cardiac cycle
are very small, about 6mmHg. This is mostly due to the fact that the portion
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Figure 4: WSS field for the grid independence study in steady state conditions.
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Figure 5: Unsteady Pressure field at different time-steps in absence of external magnetic field.
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of the circulatory system considered is limited and, therefore, the pressure drop
is small. Furthermore, on average, the pressure is higher in the Aorta than in
the coeliac trunk and the lowest values are reached inside the Hepatic Artery, at
the end of the cardiac cycle. This is due to the fact that in the coeliac trunk the
radius of the artery decreases considerably and therefore there is a high pressure
drop between this vessel and the Aorta.
Figure 5,a presents the pressure field in the Aorta at 0.05s, which is maximum
because it is in the systolic phase and the blood flows from the atria to the
ventricles. At 1s, Fig.(5,c) shows that the blood is ejected from the cardiac
chambers, so the pressure in the Aorta is the highest. At 1.15s, Fig.(5,d) reports
that the pressure is smaller in the Aorta because it is at the beginning of the
diastolic phase, and finally, between 1.5s and 2s, i.e. in the last part of the
diastolic phase, the pressure increases again in the Aorta and reaches the lowest
value inside the Hepatic artery.
The WSS in absence of external magnetic field is reported in Fig.(6). Because
of the periodicity of the profile, only some meaningful instants of time are shown.
The WSS presents a periodic pattern, which depends on the cardiac cycle. In
the last part of the systolic phase, described in Fig.(6,a), the ventricles are filled
up with blood. The velocity in the Aorta is smaller and the WSS is higher only
near the bifurcations or inside the bending branches, because some reversed flow
is present and consequently the WSS changes direction. In both bifurcations
and bends, the WSS is higher in the regions of the endothelium, where there is
fluid impingement, and lower where a detachment of the fluid vein is present.
As the cardiac cycle proceeds, the trend of the WSS remains the same.
3.4. Unsteady State Simulations with external magnetic field
The results of the particle motion in blood flow when the magnetic probe is
turned on are presented in this section. Two positions of the coil and the target
are investigated, as well as the sign of the current intensity, which makes 4 cases
studied.
Table 1 shows the coordinates of coil and target point, as well as the intensity
of the magnetic induction field, evaluated at 1cm on the axis from the center of
the coil.
The maps of the magnetic field on the artery wall are shown in Figure 7
at two different time steps, i.e. t = 1.5s and t = 2s when the particles have
filled the entire domain, and for the four different conditions presented in Table
1. The maximum value of the magnetic induction field is located close to the
liver, where the probe is directed, and as a consequence, the particles tend to
be dragged towards the coeliac trunk. The first conclusion derived from the 4
cases analyzed is that the sign of the current intensity has a minor influence on
the solution, while the distance between the coil and the target is the parameter
which affects mostly the particle dynamics.
The particle path-lines at t = 1.25s and t = 1.5s are shown in Figure 8 for
the four different conditions described in Table 1. It appears that the flow is
subject to a laminarization process. The particles on the center of the common
15
Figure 6: Unsteady WSS at different time-steps in absence of external magnetic field.
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Figure 7: Magnetic Induction Field and particle positions at different time steps, for the
different conditions listed in Table 1. (a) 1st run t = 1.5s; (b) 1st run t = 2s; (c) 2nd run
t=1.5s; (d) 2nd run t= 2s; (e) 3rd run t = 1.5s; (f) 3rd run t = 2s; (g) 4th run t=1.5s; (h)
4th run t= 2s.
17
Figure 8: Velocity Field, particle positions and velocity vectors at different time steps, for the
different conditions listed in Table 1. (a) 1st run t = 1.5s; (b) 1st run t = 2s; (c) 2nd run
t=1.5s; (d) 2nd run t= 2s; (e) 3rd run t = 1.5s; (f) 3rd run t = 2s; (g) 4th run t=1.5s; (h)
4th run t= 2s.
18
coeliac trunk tend to go into the CHA, except at t = 1.25s, i.e. on the systolic
peak, when the velocity is so high that they miss the CHA and flow directly into
the SA and LGA. At t = 1.5s, i.e. in the diastolic phase, the particles tend to
be deflected towards the bottom side of the coeliac trunk, and then transported
into the CHA. The path-lines show a helical motion which begins at the point
where the CHA originates, contributing to the increase of the local pressure
drop. Moreover, the different positions of the probe and the different sign of
the current intensity do not seem to influence the velocity field.
Figures 9 and 10 show the influence of the magnetic field on the absorption
of the particles. To put in evidence the phenomenon, also the results with the
magnetic probe turned off are reported.
Figure 9 shows the number of particles crossing a given surface per unit
time during the cardiac cycle. This variable corresponds to the particle flow
rate per unit volume. In the TA and in the domain wall the particle flow rates
are of the same order of magnitude. A peak is present around 1s because the
blood is ejected from the ventricles in the Aorta and there is a higher number
of particles inside the artery. Afterwords, the particles flow rate decreases due
to the diastolic phase. The comparison of Fig.(9,a) and Fig.(9,f) shows that
the particles flow rates in those regions do not seem to be influenced by the
parameters used in Table 1. On the contrary, on the outlets and especially on
the Hepatic Artery, it is possible to observe an increase of the particles flow,
thanks to the applied magnetic field.
The results concerning the particle flow rate may not be enough to judge the
effectiveness of the use of a rectangular coil in the magnetic targeting. Therefore,
the time integration of the particle flow rate per unit volume has been done,
which corresponds to the total number of particles that crossed a given section
since the beginning of the process. Figure 10 shows that the number of particles
is approximately the same for the five different conditions inside the TA and on
the domain wall, confirming the results shown in Figure 9. On the other hand,
the results concerning the outlets show that the magnetic field influences the
solution, because the number of particles increases in the LGA, CHA and SA,
while it decreases in the AA. The CHA seems to be the branch which is mostly
influenced by the presence of the probe. Depending on the position of the coil,
the number of particle dragged into this vessel can increase twice or three times
compared to the base case, when the probe is turned off. In particular, the last
two cases of Table 1 represent the optimal conditions for the therapy, because
they maximize the absorption of the nano-drugs in the liver, and, consequently,
they minimize the dispersion of the drug in undesired locations reducing the
side effects of the therapy.
4. Conclusions
The present work investigates via CFD the dynamics of nanoparticles in
blood flow during magnetic drug delivery. This technique is emerging as a valid
alternative to chemotherapy because of the reduced side effects. Due to the
complexity of the problem, which requires the coupling of the blood flow with
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Figure 9: Particle volumetric flow rate per unit volume vs time for the different conditions in
Table 1. B0 = no magnetic field; B1 = 1st run; B2 = 2nd run; B3 = 3rd run; B4 = 4th run.
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Figure 10: Particle number vs time for the different conditions in Table 1. B0 = no magnetic
field; B1 = 1st run; B2 = 2nd run; B3 = 3rd run; B4 = 4th run.
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the nanoparticles dynamics under the influence of an external magnetic field,
there are a few numerical studies on this subject [25–30].
The purpose of this work is to verify via numerical simulations the effective-
ness of this technique in the treatment of hepatic cancer. As every numerical
study, this is subject to the limitations due to the input parameters and the
model chosen. Nevertheless, the present hypothesis allows to describe accu-
rately the phenomena, at least from a qualitative point of view.
The numerical simulations, for steady and unsteady states, are carried out
with OpenFOAM, hypothesizing laminar flow, Newtonian viscosity for the blood
and absence of inter and intra particle forces, due to the small size of the drug
carriers. The simulations are carried out in a patient specific geometry, recon-
structed from CT slices with VMTK. Three routines are employed in Open-
FOAM to implement the BCs for the resistive pressure, the Womersley velocity
profile and the magnetic field from the rectangular coil. Furthermore, a solver
coupling the Eulerian MHD of the blood with the Lagrangian motion of particles
is developed.
One simulation with the magnetic probe turned off and four with two differ-
ent current intensities and two positions of the coil are carried out. The results
are compared in order to find the best configuration which maximizes the intake
of drug in the liver and consequently minimizes the dispersion in other locations.
The rectangular coil, pointing perpendicularly to the liver is positioned in two
points 1cm above the abdomen, and in two.
The results of the present numerical simulations show that the position of
the probe highly influences the intake in the CHA. Nevertheless, despite the
absolute number of particles flowing in this vessel can double or triple, it is still
a very small fraction of the total number of particles injected.
In all the cases studied, only a minimal amount of the drug injected, about
0.2% in the CHA, 3.3% in the LGA and 6.6% in the SA, goes to the liver after
2 seconds from the beginning of the technique. About half of the injected drug
is absorbed by the arterial wall, and the rest flows away through the AA. It was
impossible to investigate all the possible positions of the target on the abdomen
but it seems unlikely to increase significantly the drug intake in the liver by
changing the position of the probe.
This conclusion is in agreement with [27, 28], but in contrast with the nu-
merical findings of [26] for brain tumors. This is probably due to the closer
distance between the magnet and the tumor (3cm), the larger particle diam-
eter (2µm), and the higher magnetic field (1 − 4T). Magnetic drug delivery
is extremely sensitive to these parameters, it shouldn’t be surprising that the
technique performs differently in different conditions.
The low performance of the magnetic drug delivery in the present study
can be due to three factors: (i) the nanoparticle size; (ii) the magnet-tumor
distance; (iii) the probe design. As far as the nanoparticle size is concerned,
as shown in Eqs.(18-19) a low particle diameter increases the acceleration due
to the Lorentz force, but it also increases the friction. However, because of
the low magnetic field applied [50, 51] the effect on the friction is predominant.
Therefore, larger particles should increase the effectiveness of the technique.
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The probe-tumor distance is another factor which limits the effectiveness of the
technique. Unfortunately, this parameter cannot be tuned at will. If the tumor
is superficial, the magnetic drug targeting is likely to be more effective.
Finally, the design of the magnetic probe is another factor which influences
the outcome of the procedure. This conclusion was suggested in [28] as well,
where it was found that the sticking of particles to vessels occurred because of
low blood flow velocity near the vessel walls, and this was suggested to be the
main reason for low targeting efficiency.
The modulus of the magnetic induction field of a single rectangular coil
decreases considerably with the distance from the target, i.e. the liver. Being
the liver about 12cm far from the source, it is clear that this makes the modulus
of the magnetic induction considerably low. A solution to this problem could
be to increase the value of the current intensity flowing in the probe, but this is
not possible because higher values of the magnetic field could affect the health
of the patient, which is why this is forbidden by law [50, 51].
A different solution could be the employment of a different type of probe,
which must focalize most of the energy on its axis in order to reduce the rate
of decay of the magnetic field. Moreover, a possible configuration with multiple
probes, positioned in appropriate locations, could also focus a higher magnetic
field inside the target and limit the dangerous values of ~B elsewhere. A different
solution, based on the use of a time-varying magnetic field, was proposed in [28]
and showed a significant decrease in particle adherence to walls.
CFD allows detailed visualization of biological fluid flows, which increases
our understanding of natural phenomena. Yet, CFD has some limitations due
to the computational resources required to simulate a process in a complex do-
main. The question then arises as to whether or not the observation time (2s)
is sufficient to judge the effectiveness of the technique. It would be certainly
better to extend the simulations to a few minutes, but the particle volumetric
flow rate in Fig.(9) at the different cases show negligible differences. It seems
unlikely that the percentage of injected particles which reach the liver will sig-
nificantly increase over time. Nevertheless, the liver uptake could increase, if
the aortic wall would be saturated with nanoparticles. A few works have stud-
ied this problem [52–54] finding that the nanoparticle uptake is reduced for a
concentration of a few µg/ml. In this work we used a Lagrangian approach
to simulate the nonparticles flow, so the particle concentration is not directly
available. However, we can derive an average concentration by multiplying the
total number of particle injected by the mass of a single particle and dividing
it by the domain volume. After 2s we obtain an average particle concentration
of about 10−9mg/ml which is far below the saturation limit. For a particle
with dp = 500nm the saturation limit would be reached in 3 minutes, but with
the particle diameter used in this work, the saturation would not occur during
the time frame of the procedure. Moreover, the particle release from the wall
was allowed for in few numerical studies, e.g. [27, 30], but this didn’t result
in a significant increase in particle penetration into the tumor. In conclusion
it is unlikely that extending the simulation time would change significantly the
predicted efficiency of the technique.
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Further numerical simulations, in different geometries and with different
probes, are planned to assess the effectiveness of the therapy in different condi-
tions.
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